14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $137.78 $156.84 Tuesday, 23rd Apr 2024 ASND stock ended at $144.83. This is 1.92% more than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 2.90% from a day low at $143.30 to a day high of $147.45.
90 days $128.67 $161.00
52 weeks $66.03 $161.00

Historical Ascendis Pharma A/S prices

Date Open High Low Close Volume
Nov 28, 2023 $91.43 $91.77 $90.27 $90.62 216 862
Nov 27, 2023 $91.41 $92.70 $90.88 $91.41 208 156
Nov 24, 2023 $93.22 $94.25 $90.56 $92.24 173 500
Nov 22, 2023 $93.86 $94.93 $92.40 $93.00 150 789
Nov 21, 2023 $94.59 $95.66 $92.76 $93.40 161 044
Nov 20, 2023 $94.90 $97.00 $93.19 $93.76 171 379
Nov 17, 2023 $94.05 $95.17 $93.11 $94.99 218 689
Nov 16, 2023 $93.33 $93.99 $91.99 $93.50 251 438
Nov 15, 2023 $94.36 $96.00 $92.49 $92.97 288 727
Nov 14, 2023 $90.96 $95.62 $90.96 $94.70 406 956
Nov 13, 2023 $88.49 $90.49 $86.55 $89.43 387 695
Nov 10, 2023 $92.01 $92.78 $88.21 $90.28 442 199
Nov 09, 2023 $96.39 $96.95 $91.70 $92.07 330 581
Nov 08, 2023 $94.44 $95.61 $92.59 $94.74 289 724
Nov 07, 2023 $93.30 $97.85 $92.01 $96.15 466 176
Nov 06, 2023 $94.68 $95.82 $92.00 $94.41 276 008
Nov 03, 2023 $89.59 $95.23 $89.23 $94.65 355 183
Nov 02, 2023 $91.67 $92.33 $88.62 $89.29 180 776
Nov 01, 2023 $89.92 $90.82 $88.00 $90.79 214 446
Oct 31, 2023 $87.66 $89.79 $86.90 $89.31 231 609
Oct 30, 2023 $89.46 $90.63 $87.14 $87.40 179 378
Oct 27, 2023 $89.02 $90.52 $87.61 $88.27 296 209
Oct 26, 2023 $86.20 $90.53 $86.15 $89.00 307 062
Oct 25, 2023 $87.28 $87.45 $85.38 $86.30 208 209
Oct 24, 2023 $87.42 $89.12 $86.50 $88.05 164 627
Click to get the best stock tips daily for free!

About Ascendis Pharma A/S

Ascendis Pharma A/S Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra... ASND Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT